BioCentury
ARTICLE | Clinical News

CLT-28643 regulatory update

April 13, 2015 7:00 AM UTC

FDA granted Orphan Drug designation to CLT-28643 from Clanotech to prevent scarring following glaucoma surgery. The integrin alpha(5)beta(1) antagonist has Orphan Drug designation in the EU and is in...